Discover top bachelor’s degrees to kickstart your hedge fund career, including finance, economics, math, and engineering. Equip yourself with skills in demand.
Author: techrossm
The Stock Market’s $7.8 Trillion Warning Shows Investors’ Actions Speak Louder Than Their Words
Actions speak louder than words, and investors piling $7.8 trillion into money market funds pretty clearly shows they’re worried about the stock market. Depending
Stock Market News, Jan. 21, 2026: Dow ends up nearly 600 points, S&P 500 and Nasdaq jump after Trump walks away from tariff threats and says framework of a deal on Greenland is …
U.S. stocks closed sharply higher on Wednesday as investors reacted to President Trump’s decision to reverse his tariff threats against European allies.
Smallcaps under pressure: Smallcap funds hit 8-month low, yet returns show downside resilience
A mix of geopolitical uncertainty, tariff-related risks, softer earnings visibility and subdued investor risk appetite has weighed heavily on small-cap valuations, triggering a sustained
Intel’s likely to still move higher. Here’s a ‘no-cost’ options strategy to play it
Intel is an essential name to the U.S. economy and the “Soprano-like” equity ownership by the government makes me want to own this company
How Penny Stocks Differ from Small Cap Stocks: A Detailed Analysis
Explore how penny stocks and small-cap stocks differ in price, market cap, and trading platforms. Get informed to make educated investment decisions.
Dow ends lower, with S&P flat, as Intel’s outlook weighs on risk appetite
The Dow Jones Industrial Average stumbled to a lower close on Friday, while the S&P 500 ended largely unchanged, as investors’ risk appetite was
Stock market today: Dow dives 350 points; Applied Digital soars on mystery factory news (live coverage)
The Dow Jones index slides Friday despite a rise in Nvidia. The Nasdaq is acting the strongest of the major indexes.
Stock market today: Dow, S&P 500 cap volatile week with back-to-back weekly losses
US stocks were mixed on Friday, as Wall Street capped a turbulent week stoked by President Trump’s heated pursuit of Greenland while chipmaker Intel’s
What’s Happening With Moderna Stock?
In the Phase 2b trials, this combination therapy achieved a 49% decrease in the risk of recurrence or death relative to Keytruda alone, following